7/2/2008 | PP | New Issue: Biopure plans $2.3 million private placement of shares
|
10/17/2006 | BT | Biopure files for $51.75 million follow-on stock offering
|
9/12/2006 | BT | Biopure's marketing application for Hemopure accepted for U.K. review
|
9/12/2006 | BT | Biopure reaches settlement with SEC
|
9/11/2006 | BT | Biopure has $7.0 million at July 31, needs more funding
|
8/18/2006 | PP | Market Commentary: IsoRay raises $5.16 million from PIPE; FairWest sells C$3.7 million
|
8/17/2006 | PP | Market Commentary: Biopure secures $5.37 million from PIPE; BOS Better Online Solutions raises $1.5 million from notes
|
8/17/2006 | BTPP | New Issue: Biopure secures $5.37 million from private placement of units
|
7/14/2006 | BT | FDA postpones blood product advisory committee meeting
|
7/11/2006 | BT | Biopure applies for U.K. marketing authorization of Hemopure
|
5/26/2006 | BT | Biopure: FDA committee to consider Navy's proposed 'Resus' trauma trial
|
5/18/2006 | BT | Biopure 2Q revenues fall to $411,000, additional funding sought
|
4/11/2006 | BT | Former Biopure executive to pay $40,000 in civil penalty for SEC violations
|
3/21/2006 | BT | Biopure regains Nasdaq listing compliance
|
3/13/2006 | BT | Biopure says FDA to consult advisory committee on 'Resus' Hemopure trial
|
3/13/2006 | BTPP | Biopure to seek funds through possible private placements, collaborations
|
3/13/2006 | BT | Biopure reaches agreement in principle with SEC staff for settlement of litigation
|
2/16/2006 | BTPP | Biopure says 1Q revenue down to $477,000, will seek additional capital
|
1/30/2006 | BT | Biopure launches Hemopure anemia therapeutic in South Africa
|
1/13/2006 | BT | New Issue: Biopure raises $3.37 million in follow-on of 4.11 million shares at $0.82
|
1/13/2006 | BT | Market Commentary: Nektar up over 10% on Pfizer's move; Encysive, Alexion up big; Biopure loses 4% after follow-on
|
1/11/2006 | BT | Biopure launches follow-on of 4.11 million shares, plus warrants for 4.11 million shares
|
1/11/2006 | BT | Biopure to seek European Union OK for Hemopure to treat orthopedic surgery patients
|
1/4/2006 | BT | Biopure begins shipping, marketing of Hemopure in South Africa after hiring new sales agent
|
12/30/2005 | BT | Biopure greenshoe exercised, raising $6.88 million
|
12/21/2005 | BT | Market Commentary: Biopure bleeds off 13% after deal; MGI rises 11%; Sinovac up 8%; Novavax plunges 14% post close
|
12/21/2005 | BT | New Issue: Biopure raises $5.98 million in follow-on of 8.8 million shares at $0.68, also issues warrants
|
12/19/2005 | BT | Biopure says in danger of being delisted from Nasdaq National Market
|
12/7/2005 | BT | Market Commentary: Voyager IPO at bat; Amgen off; ViroPharma jumps after deal; Dendreon slides; Rigel up sharply
|
12/1/2005 | BT | Biopure launches follow-on offering of 8.8 million shares via Dawson James, Noble
|
12/1/2005 | BT | Market Commentary: Rigel Pharma tromped; Oxigene, Biopure launch follow-on deals; Lexicon, LabCorp, Quigley higher
|
11/2/2005 | BT | Biopure receives OK for phase II trial of Hemopure in U.K. amputation patients
|
10/27/2005 | BT | Biopure to begin U.K. phase II trial of Hemopure
|
12/9/2004 | PP | New Issue: Biopure receives agreements for $11.6 million direct placement
|